SUMO2 抗体 (HRP)
Quick Overview for SUMO2 抗体 (HRP) (ABIN1712569)
抗原
See all SUMO2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Sumo 2
-
亚型
- IgG
-
-
anti-Small Ubiquitin Related Modifier 2 (SUMO2) antibody
SUMO2 适用: 人, 大鼠 IHC, IF, FACS, StM 宿主: 小鼠 Monoclonal SUMO2-1199 unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 63-93) antibodySUMO2 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 1-95) antibodySUMO2 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) antibodySUMO2 适用: 人 WB, IHC, IF, FACS, StM 宿主: 小鼠 Monoclonal SM23-496 unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) antibodySUMO2 适用: 人 WB, IHC, IF 宿主: 兔 Monoclonal unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) antibodySUMO2 适用: 人, 大鼠 IF, FACS, IHC (p) 宿主: 小鼠 Monoclonal SUMO2-1199 unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 49-81) antibodySUMO2 适用: 人, 小鼠 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 1-95) antibodySUMO2 适用: 人 WB, ELISA, IHC (p) 宿主: 小鼠 Monoclonal 2H8 unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 1-93) antibodySUMO2 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal AT10F1 unconjugated
anti-Small Ubiquitin Related Modifier 2 (SUMO2) (AA 63-93), (C-Term) antibodySUMO2 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB2761 unconjugated
-
-
应用备注
-
WB: 1:100-1000, IHC-P: 1:100-500
Optimal working dilution should be determined by the investigator. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % Gentamicin.
-
储存液
- Gentamicin sulfate
-
注意事项
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at 4 °C
-
有效期
- 12 months
-
-
- SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))
-
别名
- Sumo 2
-
背景
-
The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2 and SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2, and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, SUMO-2 and SUMO-3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include IkBa, MDM2, p53, PML and Ran GAP1. SUMO-2 and SUMO-3 contribute to a greater percentage of protein modification than does SUMO-1, and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates b-Amyloid generation and may be critical in the onset or progression of Alzheimer’s disease
Synonyms: Small ubiquitin-related modier 2, SUMO-2, HSMT3, SMT3 homolog 2, SUMO-3, Sentrin-2, Ubiquitin-like protein SMT3A, Smt3A, SUMO2_HUMAN. -
基因ID
- 6613
-
途径
- Methionine Biosynthetic Process
抗原
-
